Kestra Advisory Services’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.55M Buy
407,856
+15,385
+4% +$187K 0.01% 898
2026
Q1
$5.48M Buy
392,471
+14,363
+4% +$201K 0.02% 744
2025
Q4
$5.44M Buy
378,108
+44,538
+13% +$670K 0.02% 686
2025
Q3
$5.31M Buy
+333,570
New +$5.49M 0.02% 648
2023
Q3
Sell
-46,111
Closed -$865K 2123
2023
Q2
$865K Buy
46,111
+1,969
+4% +$39.7K 0.01% 1045
2023
Q1
$900K Buy
+44,142
New +$888K 0.01% 993
2021
Q1
Sell
-19,074
Closed -$365K 1874
2020
Q4
$365K Buy
+19,074
New +$399K ﹤0.01% 1359

Other funds holding BTAL

Kestra Advisory Services's BTAL Position: Q2 2026 in Review

Kestra Advisory Services increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 3.9% in Q2 2026, buying an estimated $187K and bringing the position to 407,856 shares worth $4.55M. The position accounts for 0.01% of the portfolio, ranked #898.

Kestra Advisory Services first reported a position in BTAL in Q4 2020 and has held it in 7 quarters since. The position peaked at $5.48M in Q1 2026. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Kestra Advisory Services held 407,856 shares of AGF US Market Neutral Anti-Beta Fund worth $4.55M as of Q2 2026.
  • Kestra Advisory Services bought 15,385 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $187K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #898 holding.
  • Kestra Advisory Services first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2020 and has held it in 7 quarters since.
  • Kestra Advisory Services's AGF US Market Neutral Anti-Beta Fund position peaked at $5.48M in Q1 2026.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.